WHV hired Dr. Yegor Voronin to manage the day-to-day operation of the company and to develop the strategy for development of its PDPHV preventive HIV vaccine candidate. Dr. Voronin previously served as the Senior Science Officer at the Global HIV Vaccine Enterprise in New York. He brings over 15 years of HIV research and vaccine development expertise. Dr. Voronin holds a Ph.D. from the West Virginia University and did his postdoctoral fellow training in the laboratories of Dr. Michael Emerman and Dr. Julie Overbaugh at the Fred Hutchinson Cancer Research Center, Seattle.
